AJOVista’s Tyra Biosciences TYRA Stock Holding History

AJOVista’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,235	Closed	-$58.7K	–	397
2023 Q4	$58.7K	Buy	+4,235	New	+$54.8K	0.07%	267

Other funds holding TYRA

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

AJOVista's TYRA Position: Q1 2024 in Review

AJOVista sold out of Tyra Biosciences (TYRA) in Q1 2024, closing a stake of 4,235 shares — an estimated $58.7K sold.

AJOVista first reported a position in TYRA in Q4 2023 and held it in 1 quarter. The position peaked at $58.7K in Q4 2023. 77 funds tracked by Wall St. Rank hold TYRA as of Q1 2024.

AJOVista reported no remaining Tyra Biosciences position as of Q1 2024 after selling out during the quarter.
AJOVista sold 4,235 Tyra Biosciences shares in Q1 2024, an estimated $58.7K.
AJOVista first reported a position in Tyra Biosciences in Q4 2023 and held it in 1 quarter.
AJOVista's Tyra Biosciences position peaked at $58.7K in Q4 2023.
77 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.